SSBB partner in the spotlight: InBiose
InBiose, founded in 2013 as a spinoff from the University of Ghent, is now the biggest private research group in the world of specialty glycan. It is a leading B2B …
News
Molecular dynamics simulations
Molecular dynamics (MD) is a powerful computational tool used to model biological processes and explore their mechanisms at the atomic/molecular level. This technique has enabled us to investigate atom-to-atom interactions …
Can Artificial Intelligence Save Us from Antimicrobial Resistance? Spoiler: It’s Already Starting to!
Antimicrobial resistance (AMR) is a global health emergency that already causes over 1.2 million deaths every year. But here’s the good news: AI-driven drug discovery is no longer a promise, …
Promising antimicrobial agents against strong biofilm-forming P. aeruginosa
The antimicrobial peptides (AMPs) SET-M33L and SET-M33L-PEG were investigated against 10 clinical isolates of P. aeruginosa. Their minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs), and minimum biofilm inhibitory concentrations (MBICs) …
Promising antimicrobial agents against strong biofilm-forming P. aeruginosa Read More »
Behind the Scenes: The Journey of a Novel Drug from Lab to Pharmacy
Before any treatment becomes available to patients, it must be proven to be both effective and safe. This involves a long (often 10-15 years), complex and multi-stage process of drug …
Behind the Scenes: The Journey of a Novel Drug from Lab to Pharmacy Read More »
Antimicrobial resistance: A silent threat to public health
Antimicrobial resistance, or AMR, is often called a “silent pandemic” because it is happening quietly all around us. It occurs when bacteria learn how to survive the medicines that once …
Antimicrobial resistance: A silent threat to public health Read More »
It´s giving resistance… and that´s not cool!
Antimicrobial resistance (AMR) is growing into one of the most significant public health challenges of our time. The World Health Organization claims it is among the main public health threats in the history. 🔬 What …
Implant material governs SET-M33’s antimicrobial effectiveness
Four SSBB doctoral candidates from three different partners worked together and published a paper about the efficacy of the SET-M33 antimicrobial peptide in combination with different implant materials that enter …
Implant material governs SET-M33’s antimicrobial effectiveness Read More »
Ismael Castañón secondment at Hylomorph in Switzerland
During January and February 2025, Ismael Castañón carried out research at Hylomorph as part of a collaborative project between Hylomorph (Switzerland) and SetLance (Italy), focused on the development of dual-affinity …
Ismael Castañón secondment at Hylomorph in Switzerland Read More »
SSBB Consortium meeting in Rotterdam
From January 22nd to 24th, the 4th Consortium Meeting of the Stop Spread Bad Bugs project and PhD training took place at Erasmus MC! Our PhD researchers, alongside our partners, …
